Welcome to Ligand Pharmaceuticals

Ligand is a high-growth company with economic rights to some of the world's most important medicines.

Portfolio
Technologies
Licensing Opportunities

Investor Relations

View Investor Relations

Latest News

Ligand to Participate in the H. C. Wainwright 21st Annual Global Investment Conference

Read More

Ligand Partner CASI Pharmaceuticals Launches EVOMELA® in China

Read More

Ligand Reports Second Quarter 2019 Financial Results

Read More

Recent Events

Stock Snapshot

LGND
Nasdaq
Volume
Market Cap
Day Range
52-Week Range